Marie Thibault
Stock Analyst at BTIG
(0.11)
# 4,792
Out of 5,118 analysts
771
Total ratings
42.2%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Reiterated: Buy | $130 → $142 | $119.93 | +18.40% | 16 | Nov 5, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $185 → $170 | $90.22 | +88.43% | 63 | Nov 5, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $70 | $53.29 | +31.36% | 3 | Nov 5, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $5.68 | +76.06% | 10 | Nov 4, 2026 | |
| PODD Insulet | Reiterated: Hold | n/a | $146.51 | - | 52 | Nov 4, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $55 → $70 | $58.54 | +19.58% | 55 | Nov 3, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $30 | $26.59 | +12.82% | 15 | Nov 3, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $56 → $49 | $42.75 | +14.62% | 81 | Oct 28, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $134 → $125 | $109.93 | +13.71% | 55 | Oct 21, 2026 | |
| EMBC Embecta | Reiterated: Hold | n/a | $6.19 | - | 29 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $102.14 | +7.70% | 46 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.7195 | +177.97% | 9 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $16.71 | +67.56% | 6 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.59 | - | 41 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $28.80 | +11.11% | 12 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $90 | $79.41 | +13.34% | 56 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $17 | $14.93 | +13.86% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.16 | - | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.11 | - | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.23 | +254.61% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $67.02 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $342.37 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $319.21 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $101.80 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.15 | n/a | 23 | Dec 16, 2022 |
Haemonetics
Nov 5, 2026
Reiterated: Buy
Price Target: $130 → $142
Current: $119.93
Upside: +18.40%
iRhythm Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $185 → $170
Current: $90.22
Upside: +88.43%
Pulse Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $70
Current: $53.29
Upside: +31.36%
Orchestra BioMed Holdings
Nov 4, 2026
Reiterated: Buy
Price Target: $10
Current: $5.68
Upside: +76.06%
Insulet
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $146.51
Upside: -
AtriCure
Nov 3, 2026
Reiterated: Buy
Price Target: $55 → $70
Current: $58.54
Upside: +19.58%
CeriBell
Nov 3, 2026
Reiterated: Buy
Price Target: $30
Current: $26.59
Upside: +12.82%
Boston Scientific
Oct 28, 2026
Reiterated: Buy
Price Target: $56 → $49
Current: $42.75
Upside: +14.62%
Abbott Laboratories
Oct 21, 2026
Reiterated: Buy
Price Target: $134 → $125
Current: $109.93
Upside: +13.71%
Embecta
Oct 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.19
Upside: -
Oct 9, 2026
Reiterated: Buy
Price Target: $110
Current: $102.14
Upside: +7.70%
Oct 9, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7195
Upside: +177.97%
Oct 9, 2026
Reiterated: Buy
Price Target: $28
Current: $16.71
Upside: +67.56%
Oct 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.59
Upside: -
Sep 15, 2026
Reiterated: Buy
Price Target: $32
Current: $28.80
Upside: +11.11%
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $79.41
Upside: +13.34%
Jul 13, 2026
Reiterated: Buy
Price Target: $16 → $17
Current: $14.93
Upside: +13.86%
Jul 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.16
Upside: -
Jul 7, 2026
Rated: Hold
Price Target: n/a
Current: $0.11
Upside: -
Feb 18, 2026
Reiterated: Buy
Price Target: $15
Current: $4.23
Upside: +254.61%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $67.02
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $342.37
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $319.21
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $101.80
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $2.15
Upside: n/a